When Centene CEO Sarah London took the helm in 2022, she oversaw the divestiture of several of the company’s non-core businesses. The process of selling off non-core assets is mostly complete, executives said.
“We were still investing in ensuring we had eyes on the landscape and were cultivating a very active pipeline,” Ms. London told investors. “One of the great things about where we are right now, as we think about 2025 and beyond, is we have incrementally more operating bandwidth and oxygen to think about those things.”
CFO Drew Asher said the company is focused on acquiring health plans and companies that could boost its efforts in ICHRA and dual-eligible markets. Executives told investors these two markets are where it sees the best opportunities for disruption.
“We would love to acquire some businesses, health plans, that add to our core business or help accelerate some of our disruptive opportunities,” Mr. Asher said.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
